Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Despite Exercise Benefits, Some People Like to Strive More to Prevent Diabetes

    While exercise is good for everyone, it is also a well known fact that some struggle more than others, suggested a recent study by researchers at Lund University. The researchers studied the effects of exercise in people with increased risk of type 2 diabetes caused by being immediately related to someone with the disease. The study is published in Journal of Applied Physiology.

  • Sandoz's BLA For Biosimilar Etanercept Accepted by USFDA

    Sandoz, a Novartis company and the global leader in biosimilars, announced that US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Enbrel (etanercept) - a tumour necrosis factor alpha (TNF-alpha) inhibitor. This is the second BLA submission by Sandoz using the 351(k) biosimilar pathway.

Subscribe to Pharma News

Search this website